145 related articles for article (PubMed ID: 25443083)
21. Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using 201Tl-SPECT.
Tie J; Gunawardana DH; Rosenthal MA
J Clin Neurosci; 2008 Dec; 15(12):1327-34. PubMed ID: 18845440
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis.
Wan B; Wang S; Tu M; Wu B; Han P; Xu H
Medicine (Baltimore); 2017 Mar; 96(11):e6333. PubMed ID: 28296759
[TBL] [Abstract][Full Text] [Related]
23. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
[TBL] [Abstract][Full Text] [Related]
24. Molecular imaging based on differential protein content in differentiating glioma from radiation necrosis.
Jandial R; Duenas VJ; Chen BT
Neurosurgery; 2011 Jun; 68(6):N16-7. PubMed ID: 21778943
[No Abstract] [Full Text] [Related]
25. Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.
Yu Y; Ma Y; Sun M; Jiang W; Yuan T; Tong D
Medicine (Baltimore); 2020 Jun; 99(23):e20270. PubMed ID: 32501974
[TBL] [Abstract][Full Text] [Related]
26. The performance of 11C-Methionine PET in the differential diagnosis of glioma recurrence.
Xu W; Gao L; Shao A; Zheng J; Zhang J
Oncotarget; 2017 Oct; 8(53):91030-91039. PubMed ID: 29207622
[TBL] [Abstract][Full Text] [Related]
27. [Importance of cerebral tomoscintigraphy using technetium-labeled sestamibi in the differential diagnosis of current tumor vs. radiation necrosis in subtentorial glial tumors in the adult].
Lamy-Lhullier C; Dubois F; Blond S; Lecouffe P; Steinling M
Neurochirurgie; 1999 May; 45(2):110-7. PubMed ID: 10448650
[TBL] [Abstract][Full Text] [Related]
28. Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities.
Smith EJ; Naik A; Shaffer A; Goel M; Krist DT; Liang E; Furey CG; Miller WK; Lawton MT; Barnett DH; Weis B; Rizk A; Smith RS; Hassaneen W
J Neurooncol; 2023 Mar; 162(1):15-23. PubMed ID: 36853489
[TBL] [Abstract][Full Text] [Related]
29. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
[TBL] [Abstract][Full Text] [Related]
30. Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma.
Nael K; Bauer AH; Hormigo A; Lemole M; Germano IM; Puig J; Stea B
AJR Am J Roentgenol; 2018 Jan; 210(1):18-23. PubMed ID: 28952810
[TBL] [Abstract][Full Text] [Related]
31. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
[TBL] [Abstract][Full Text] [Related]
32. Role of magnetic resonance spectroscopy to differentiate high-grade gliomas from metastases.
Wang Q; Zhang J; Xu W; Chen X; Zhang J; Xu B
Tumour Biol; 2017 Jun; 39(6):1010428317710030. PubMed ID: 28631566
[TBL] [Abstract][Full Text] [Related]
33. Brain SPECT by 99mTc-tetrofosmin for the differentiation of tumor recurrence from radiation injury.
Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
J Nucl Med; 2008 Oct; 49(10):1733-4; author reply 1734. PubMed ID: 18794274
[No Abstract] [Full Text] [Related]
34. [Differential diagnosis between recurrence of gliomas and radiation necrosis by 201TlCl SPECT].
Nakamura O; Kosuda S; Okamoto K; Kaneko M; Nakamura H; Shitara N; Suzuki K
No To Shinkei; 1994 Nov; 46(11):1051-7. PubMed ID: 7873278
[TBL] [Abstract][Full Text] [Related]
35. Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?
Shah AH; Snelling B; Bregy A; Patel PR; Tememe D; Bhatia R; Sklar E; Komotar RJ
J Neurooncol; 2013 Apr; 112(2):141-52. PubMed ID: 23344789
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis comparing 18F-FLT PET with 18F-FDG PET for assessment of brain tumor recurrence.
Li Z; Yu Y; Zhang H; Xu G; Chen L
Nucl Med Commun; 2015 Jul; 36(7):695-701. PubMed ID: 25768337
[TBL] [Abstract][Full Text] [Related]
37. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.
Jena A; Taneja S; Gambhir A; Mishra AK; Dʼsouza MM; Verma SM; Hazari PP; Negi P; Jhadav GK; Sogani SK
Clin Nucl Med; 2016 May; 41(5):e228-36. PubMed ID: 26859208
[TBL] [Abstract][Full Text] [Related]
38. [Differentiation between glioma recurrence and radiation-induced brain injuries using perfusion-weighted magnetic resonance imaging].
Wang YL; Liu MY; Wang Y; Xiao HF; Sun L; Zhang J; Ma L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):416-21. PubMed ID: 23987489
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine.
Kuwert T; Woesler B; Morgenroth C; Lerch H; Schäfers M; Palkovic S; Matheja P; Brandau W; Wassmann H; Schober O
J Nucl Med; 1998 Jan; 39(1):23-7. PubMed ID: 9443732
[TBL] [Abstract][Full Text] [Related]
40. Application value of apparent diffusion coefficient in differentiation of brain radiation-injuries and glioma recurrence.
Wang YL; Liu MY; Li JF; Zhang J; Sun L; Feng F; Ma L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug; 34(4):396-400. PubMed ID: 22954125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]